BLACKSMITH PIPELINE

At Forge Therapeutics, we have utilized our innovative drug discovery BLACKSMITH platform to identify selective metal-binding pharmacophore fragments. Then, using bioinorganic and medicinal chemistry principles, we develop potent full-length inhibitors through a novel fragment growth strategy incorporating computational and structural biology.

PIPELINE

FIND OUT MORE ABOUT THE BLACKSMITH PROCESS

BLACKSMITH PROCESS